Bonnie E. Lonze

ORCID: 0000-0002-0973-1657
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • Organ Donation and Transplantation
  • Renal Diseases and Glomerulopathies
  • Transplantation: Methods and Outcomes
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Renal and Vascular Pathologies
  • Complement system in diseases
  • Hepatitis B Virus Studies
  • Dialysis and Renal Disease Management
  • Polyomavirus and related diseases
  • Diabetes Treatment and Management
  • Pharmaceutical industry and healthcare
  • Frailty in Older Adults
  • Nerve injury and regeneration
  • Xenotransplantation and immune response
  • SARS-CoV-2 and COVID-19 Research
  • Pregnancy and Medication Impact
  • Pharmacological Effects and Toxicity Studies
  • Systemic Lupus Erythematosus Research
  • Nutrition and Health in Aging
  • Organ and Tissue Transplantation Research
  • Axon Guidance and Neuronal Signaling
  • Palliative Care and End-of-Life Issues

New York University
2017-2025

NYU Langone Health
2017-2025

Miami Transplant Institute
2017-2025

Johns Hopkins Medicine
2008-2023

Johns Hopkins University
2009-2023

Saint Louis University
2023

Jefferson College
2023

Aarhus University
2023

Thomas Jefferson University
2023

Jefferson College of Health Sciences
2023

More than 20,000 candidates for kidney transplantation in the United States are sensitized to HLA and may have a prolonged wait transplant, with reduced rate an increased of death. One solution is perform live-donor renal after depletion donor-specific anti-HLA antibodies. Whether such antibody results survival benefit as compared waiting HLA-compatible unknown.We used protocol that included plasmapheresis administration low-dose intravenous immune globulin desensitize 211 HLA-sensitized...

10.1056/nejmoa1012376 article EN New England Journal of Medicine 2011-07-27

Xenografts from genetically modified pigs have become one of the most promising solutions to dearth human organs available for transplantation. The challenge in this model has been hyperacute rejection. To avoid this, bred with a knockout alpha-1,3-galactosyltransferase gene and subcapsular autologous thymic tissue.We transplanted kidneys these into two brain-dead recipients whose circulatory respiratory activity was maintained on ventilators duration study. We performed serial biopsies...

10.1056/nejmoa2120238 article EN New England Journal of Medicine 2022-05-18

Key Points Posoleucel was generally safe, well tolerated, and associated with a greater reduction of BK viremia compared placebo. occurred coincident an increase in the circulating frequency virus–specific T cells posoleucel recipients. The presence persistence confirmed by T-cell receptor variable β sequencing. Background Kidney transplant recipients virus infection are at risk developing virus–associated nephropathy, allograft rejection, subsequent graft loss. There no approved treatments...

10.1681/asn.0000000000000329 article EN Journal of the American Society of Nephrology 2024-03-12

Cyclic AMP response element-binding protein (CREB) is a widely expressed transcription factor whose role in neuronal protection now well established. Here we report that CREB present the mitochondrial matrix of neurons and it binds directly to cyclic elements (CREs) found within genome. Disruption activity mitochondria decreases expression subset genes, including ND5 subunit complex I, down-regulates I-dependent respiration, increases susceptibility 3-nitropropionic acid, toxin induces...

10.1074/jbc.c500140200 article EN cc-by Journal of Biological Chemistry 2005-10-06

We report that developmental competition between sympathetic neurons for survival is critically dependent on a sensitization process initiated by target innervation and mediated series of feedback loops. Target-derived nerve growth factor (NGF) promoted expression its own receptor TrkA in mouse rat prolonged TrkA-mediated signals. NGF also controlled brain-derived neurotrophic neurotrophin-4, which, through the p75, can kill neighboring with low retrograde NGF-TrkA signaling whereas high are...

10.1126/science.1152677 article EN Science 2008-03-07

To test whether frailty, a novel measure of physiologic reserve, is associated with longer kidney transplant (KT) length stay (LOS), and modifies the association between LOS mortality.Better understanding necessary for informed consent discharge planning. Mortality resulting from has important regulatory implications hospital programs. Which recipients are at risk prolonged its effect on mortality unclear. Frailty preoperative predictor poor KT outcomes including delayed graft function,...

10.1097/sla.0000000000002025 article EN Annals of Surgery 2016-09-21

Renal transplantation in patients with antiphospholipid antibodies has historically proven challenging due to increased risk for thrombosis and allograft failure. This is especially true antibody syndrome (APS) its rare subtype, the catastrophic (CAPS). Since a critical mechanism of APS/CAPS one mediated by complement activation, we hypothesized that preemptive treatment terminal inhibitor, eculizumab, would reduce extent vascular injury thrombosis, enabling renal whom it otherwise be...

10.1111/ajt.12540 article EN cc-by-nc-nd American Journal of Transplantation 2014-01-08

Frailty increases early hospital readmission and mortality risk among kidney transplantation (KT) recipients. Although frailty represents a high-risk state for this population, the correlates of frailty, patterns 5 components, associated with these are unclear.Six hundred sixty-three KT recipients were enrolled in cohort study (12/2008-8/2015). Frailty, activities daily living (ADL)/instrumental ADL (IADL) disability, Centers Epidemiologic Studies Depression Scale depression, education,...

10.1097/tp.0000000000001546 article EN Transplantation 2016-10-25

Background Incompatible live donor kidney transplantation is associated with an increased rate of antibody-mediated rejection (AMR) and subsequent transplant glomerulopathy. For patients severe, oliguric AMR, graft loss inevitable without timely intervention. Methods We reviewed our experience rescuing allografts this severe AMR phenotype by using splenectomy alone (n=14), eculizumab (n=5), or plus in addition to plasmapheresis. Results The study population was 267 consecutive donor-specific...

10.1097/tp.0000000000000298 article EN Transplantation 2014-08-14

Objectives: The presence of a donor-specific positive crossmatch has been considered to be contraindication kidney transplantation because the risk hyperacute rejection. Desensitization is process removing hazardous preformed antibody (DSA) in order safely proceed with transplant. Traditionally, this involves plasmapheresis and intravenous immune globulin treatments that occur over days weeks, feasible when there living donor date transplant known, allowing time for pre-emptive treatments....

10.1097/sla.0000000000002924 article EN Annals of Surgery 2018-07-14

The Kidney Allocation System (KAS), a major change to deceased donor kidney allocation, was implemented in December 2014. Goals of KAS included directing the highest-quality organs younger/healthier recipients and increasing access transplantation (DDKT) for highly sensitized patients racial/ethnic minorities. Using national registry data, we compared distribution, DDKT rates waitlist registrants, recipient characteristics between January 1, 2013, 3, 2014 (pre-KAS) with those 4, 2014, August...

10.1681/asn.2015080934 article EN Journal of the American Society of Nephrology 2015-12-17

Background. Highly HLA sensitized patients have limited access to life-saving kidney transplantation because of a paucity immunologically suitable donors. Imlifidase is cysteine protease that cleaves IgG leading rapid decrease in antibody level and inhibition IgG-mediated injury. This study investigates the efficacy safety imlifidase converting positive crossmatch test negative, allowing highly be transplanted with living or deceased donor kidney. Methods. open-label, single-arm, phase 2...

10.1097/tp.0000000000003496 article EN cc-by-nc-nd Transplantation 2020-10-22

Imlifidase is a cysteine proteinase which specifically cleaves IgG, inhibiting Fc-mediated effector function within hours of administration. converts positive crossmatch to potential donor (T cell, B or both), negative, enabling transplantation occur between previously HLA incompatible donor-recipient pairs. To date, 39 patients received imlifidase prior kidney transplant in four single-arm, open-label, phase 2 studies. At 3 years, for who were AMR+ compared AMR-, death-censored allograft...

10.1111/ajt.16754 article EN cc-by-nc American Journal of Transplantation 2021-07-08

The recent national focus on patient safety has led to a re-examination of the risks and benefits nighttime surgery. In liver transplantation, hypothetical operation must be weighed against either well-established prolonging cold ischemia or potential strategies manipulate operative start times. A retrospective review was conducted 578 transplants performed at single institution between 1995 2008 determine whether incidence postoperative complications correlated with We hypothesized that no...

10.1111/j.1600-6143.2010.03177.x article EN cc-by-nc-nd American Journal of Transplantation 2010-07-23

The updated Banff classification allows for the diagnosis of antibody-mediated rejection (AMR) in absence peritubular capillary C4d staining. Our objective was to quantify allograft loss risk patients with consistently C4d-negative AMR (n = 51) compared C4d-positive 156) and matched control subjects without AMR. All first-year posttransplant biopsy results from January 2004 through June 2014 were reviewed correlated presence donor-specific antibody (DSA). not different on any baseline...

10.1111/ajt.13434 article EN cc-by-nc-nd American Journal of Transplantation 2015-08-28

In Brief Background Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage renal disease with high rate recurrence after kidney transplantation. Several factors, such as white race, rapid progression, and previous allograft failure due to recurrence, were found be risks recurrence. Data are limited on the benefits rituximab and/or therapeutic plasma exchange (TPE) in preventing this study, we sought assess efficacy TPE for prevention treatment recurrent FSGS Methods We...

10.1097/tp.0000000000002008 article EN Transplantation 2017-11-21
Coming Soon ...